WHO ICTRP trial

Improving Gum Infection Treatment using a New combination of blood product and…

CTRI/2025/05/087134 · Clinical Trials Registry India (CTRI) · Not Recruiting

Key facts

Trial ID CTRI/2025/05/087134
Public title Improving Gum Infection Treatment using a New combination of blood product and antibiotic drug
Scientific title Clinical and microbiological analysis of biofunctionalized metronidazole as an adjunctive local drug delivery system in non-surgical treatment of periodontal abscess - NIL
Primary sponsor Dr T Jaya Sree
Registry Clinical Trials Registry India (CTRI)
Recruitment status Not Recruiting
Study type Interventional
Phase Phase 3
Countries India
Conditions Health Condition 1: K055- Other periodontal diseases
Interventions Intervention1: Metronidazole enriched injectable Platelet rich fibrin: Metronidazole enriched Platelet rich fibrin group will receive scaling followed by drainage of the periodontal abscess followed by the placement of Metronidazole…
Registration date May 20, 2025
Target size 33
Secondary IDs NIL
Registry page ctri.nic.in

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations